{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.1444.3.144","meta":{"versionId":"6","lastUpdated":"2021-03-06T01:00:18.000-05:00"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.144","version":"20210306","name":"Netupitant Palonosetron Oral","status":"active","date":"2021-03-06T01:00:18-05:00","publisher":"American Society of Clinical Oncology Steward","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","concept":[{"code":"1552343","display":"netupitant 300 MG / palonosetron 0.5 MG Oral Capsule"}]}]},"expansion":{"identifier":"urn:uuid:3a79e01b-0be2-4638-9955-93c543cc60c3","timestamp":"2022-06-10T10:04:15-04:00","total":1,"offset":0,"parameter":[{"name":"count","valueInteger":1000},{"name":"offset","valueInteger":0}],"contains":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"1552343","display":"netupitant 300 MG / palonosetron 0.5 MG Oral Capsule"}]}}